My watch list
my.bionity.com  
Login  

34 Current news about the topic ulcerative colitis

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

AM-Pharma announces 2.5 million EURO financing

AM-Pharma financing kick-starts Series C financing effort

07-Aug-2007

AM-Pharma B.V., a biopharmaceutical company developing improved endogenous proteins to combat disease, announced the signing of a 2.5 million Euro financing agreement with its two main investors, Forbion Capital Partners and Inventages Venture Capital. The investment is a prelude to a Series C ...

more

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis

05-Jul-2007

Chi-Med, the Hutchison Whampoa backed pharmaceutical and healthcare Group, announced positive results for its Phase II proof-of-concept study for HMPL-004 in mild-to-moderate Ulcerative Colitis, a form of inflammatory bowel disease. The trial met its objective in that HMPL-004 was well tolerated ...

more

A Full Pipeline of Follow-on TNF-Antagonists

The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds

03-Aug-2006

The Business Intelligence firm La Merie S.L. reported that the huge market of US$ 7.6 bln in 2005 and the clinical validation of the target in many inflammatory indications has filled the pipeline of follow-on TNF-antagonists. Sales of the three marketed TNF antagonists etanercept, infliximab and ...

more

Genzyme, MacroGenics Announce Joint Effort to Develop New Therapies for Immune-Mediated Diseases

04-Nov-2003

Genzyme Corp. and MacroGenics, Inc. announced that they have entered into a strategic partnership to develop novel therapies for immune-mediated diseases. Under the agreement, the companies will work together to advance MacroGenics' ongoing preclinical program targeting the Fc receptor CD16, an ...

more

Page 4 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE